Pages that link to "Q35822592"
Jump to navigation
Jump to search
The following pages link to In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis (Q35822592):
Displaying 22 items.
- Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria (Q33534711) (← links)
- Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis (Q33654490) (← links)
- Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children wit (Q33692927) (← links)
- Bacterial meningitis (Q33750256) (← links)
- Bacterial meningitis in children (Q33929062) (← links)
- Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children (Q33964352) (← links)
- Emergence in france of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin (Q33976988) (← links)
- Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically ac (Q33977786) (← links)
- Emergence in Vietnam of Streptococcus pneumoniae resistant to multiple antimicrobial agents as a result of dissemination of the multiresistant Spain(23F)-1 clone (Q34142244) (← links)
- Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis (Q35118221) (← links)
- Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae (Q35119049) (← links)
- Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile (Q35120392) (← links)
- Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. (Q35125164) (← links)
- Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model (Q35126962) (← links)
- First Report of a Case of Pneumococcal Meningitis Which Did Not Respond to the Ceftriaxone Therapy despite the Isolated Organism Being Sensitive to This Antibiotic In Vitro. (Q38039435) (← links)
- Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae (Q39784239) (← links)
- Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections (Q40675256) (← links)
- A Closer Look at Vancomycin, Teicoplanin, and Antimicrobial Resistance (Q41646436) (← links)
- Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait (Q43593192) (← links)
- Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae (Q45064646) (← links)
- Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis. (Q46120014) (← links)
- In vitro killing of penicillin-suseceptible, -intermediate, and -resistant strains of streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: A comparison of bactericidal and inhibitory activity with achievable CSF levels (Q54174598) (← links)